Literature DB >> 19770298

Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.

Riham H El Khouli1, Katarzyna J Macura, Michael A Jacobs, Tarek H Khalil, Ihab R Kamel, Andrew Dwyer, David A Bluemke.   

Abstract

OBJECTIVE: The type of contrast enhancement kinetic curve (i.e., persistently enhancing, plateau, or washout) seen on dynamic contrast-enhanced MRI (DCE-MRI) of the breast is predictive of malignancy. Qualitative estimates of the type of curve are most commonly used for interpretation of DCE-MRI. The purpose of this study was to compare qualitative and quantitative methods for determining the type of contrast enhancement kinetic curve on DCE-MRI.
MATERIALS AND METHODS: Ninety-six patients underwent breast DCE-MRI. The type of DCE-MRI kinetic curve was assessed qualitatively by three radiologists on two occasions. For quantitative assessment, the slope of the washout curve was calculated. Kappa statistics were used to determine inter- and intraobserver agreement for the qualitative method. Matched sample tables, the McNemar test, and receiver operating characteristic (ROC) curve statistics were used to compare quantitative versus qualitative methods for establishing or excluding malignancy.
RESULTS: Seventy-eight lesions (77.2%) were malignant and 23 (22.8%) were benign. For the qualitative assessment, the intra- and interobserver agreement was good (kappa = 0.76-0.88), with an area under the ROC curve (AUC) of 0.73-0.77. For the quantitative method, the highest AUC was 0.87, reflecting significantly higher diagnostic accuracies compared with qualitative assessment (p < 0.01 for the difference between the two methods).
CONCLUSION: Quantitative assessment of the type of contrast enhancement kinetic curve on breast DCE-MRI resulted in significantly higher diagnostic performance for establishing or excluding malignancy compared with assessment based on the standard qualitative method.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770298      PMCID: PMC3034220          DOI: 10.2214/AJR.09.2483

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.

Authors:  K Kinkel; T H Helbich; L J Esserman; J Barclay; E H Schwerin; E A Sickles; N M Hylton
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

2.  A combined architectural and kinetic interpretation model for breast MR images.

Authors:  M D Schnall; S Rosten; S Englander; S G Orel; L W Nunes
Journal:  Acad Radiol       Date:  2001-07       Impact factor: 3.173

3.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.

Authors:  Christiane K Kuhl; Hans H Schild; Nuschin Morakkabati
Journal:  Radiology       Date:  2005-09       Impact factor: 11.105

4.  Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging.

Authors:  Mark J Stoutjesdijk; Jurgen J Fütterer; Carla Boetes; Lya E van Die; Gerrit Jager; Jelle O Barentsz
Journal:  Invest Radiol       Date:  2005-06       Impact factor: 6.016

5.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

Authors:  Christiane K Kuhl; Simone Schrading; Claudia C Leutner; Nuschin Morakkabati-Spitz; Eva Wardelmann; Rolf Fimmers; Walther Kuhn; Hans H Schild
Journal:  J Clin Oncol       Date:  2005-11-20       Impact factor: 44.544

6.  Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients.

Authors:  N E Hawass
Journal:  Br J Radiol       Date:  1997-04       Impact factor: 3.039

7.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

8.  Magnetic resonance imaging of the breast prior to biopsy.

Authors:  David A Bluemke; Constantine A Gatsonis; Mei Hsiu Chen; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola Hylton; Christiane K Kuhl; Constance Lehman; Etta D Pisano; Petrina Causer; Stuart J Schnitt; Stanley F Smazal; Carol B Stelling; Paul T Weatherall; Mitchell D Schnall
Journal:  JAMA       Date:  2004-12-08       Impact factor: 56.272

Review 9.  Patterns of enhancement on breast MR images: interpretation and imaging pitfalls.

Authors:  Katarzyna J Macura; Ronald Ouwerkerk; Michael A Jacobs; David A Bluemke
Journal:  Radiographics       Date:  2006 Nov-Dec       Impact factor: 5.333

10.  Detection of breast malignancy: diagnostic MR protocol for improved specificity.

Authors:  Wei Huang; Paul R Fisher; Khaldoon Dulaimy; Luminita A Tudorica; Brian O'Hea; Terry M Button
Journal:  Radiology       Date:  2004-06-17       Impact factor: 11.105

View more
  57 in total

1.  (1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.

Authors:  Waka Mizukoshi; Eito Kozawa; Kaiji Inoue; Naoko Saito; Naoko Nishi; Toshiaki Saeki; Fumiko Kimura
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

2.  Ultrasound elastography and magnetic resonance examinations are effective for the accurate diagnosis of mammary duct ectasia.

Authors:  Feixue Zhang; Dexin Yu; Mingming Guo; Qing Wang; Zhigang Yu; Fei Zhou; Meng Zhao; Feng Xue; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging.

Authors:  Johan Coolen; Johan Vansteenkiste; Frederik De Keyzer; Herbert Decaluwé; Walter De Wever; Christophe Deroose; Christophe Dooms; Eric Verbeken; Paul De Leyn; Vincent Vandecaveye; Dirk Van Raemdonck; Kristiaan Nackaerts; Steven Dymarkowski; Johny Verschakelen
Journal:  Eur Radiol       Date:  2013-10-31       Impact factor: 5.315

4.  Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.

Authors:  Alana R Amarosa; Jason McKellop; Ana Paula Klautau Leite; Melanie Moccaldi; Tess V Clendenen; James S Babb; Anne Zeleniuch-Jacquotte; Linda Moy; Sungheon Kim
Journal:  Radiology       Date:  2013-05-08       Impact factor: 11.105

Review 5.  A review of breast tomosynthesis. Part II. Image reconstruction, processing and analysis, and advanced applications.

Authors:  Ioannis Sechopoulos
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

6.  Idiopathic Granulomatous Mastitis Associated with Erythema Nodosum.

Authors:  Tuğçe Özlem Kalaycı; Melike Bedel Koruyucu; Melda Apaydın; Demet Etit; Makbule Varer
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

7.  Automatic segmentation of invasive breast carcinomas from dynamic contrast-enhanced MRI using time series analysis.

Authors:  Jagadaeesan Jayender; Sona Chikarmane; Ferenc A Jolesz; Eva Gombos
Journal:  J Magn Reson Imaging       Date:  2013-09-23       Impact factor: 4.813

8.  Differentiation of malignant and benign breast lesions using magnetization transfer imaging and dynamic contrast-enhanced MRI.

Authors:  Samantha L Heller; Linda Moy; Sherlin Lavianlivi; Melanie Moccaldi; Sungheon Kim
Journal:  J Magn Reson Imaging       Date:  2012-10-23       Impact factor: 4.813

9.  Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.

Authors:  Daniel Stocker; Stefanie Hectors; Octavia Bane; Naik Vietti-Violi; Daniela Said; Paul Kennedy; Jordan Cuevas; Guilherme M Cunha; Claude B Sirlin; Kathryn J Fowler; Sara Lewis; Bachir Taouli
Journal:  Eur Radiol       Date:  2021-05-27       Impact factor: 5.315

10.  Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.

Authors:  Savannah C Partridge; Karen M Stone; Roberta M Strigel; Wendy B DeMartini; Sue Peacock; Constance D Lehman
Journal:  Acad Radiol       Date:  2014-07-04       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.